Telihep Trio 6.25 Tablet
Marketer
Daylon Healthcare
Salt Composition
Telmisartan (40mg) + Cilnidipine (10mg) + Chlorthalidone (6.25mg)
Overview Telihep Trio 6.25 Tablet
Combipress HT 6.25mg is a triple-drug formulation for managing hypertension when monotherapy proves insufficient. It effectively lowers elevated blood pressure, thereby mitigating the risk of future cardiovascular events like stroke and heart attack. Administer Combipress HT 6.25mg with food, at the same time daily, and as directed by your physician. Continue treatment as prescribed; discontinuation may increase stroke or heart attack risk. The medication includes a diuretic, increasing urination, so avoid dosing within four hours of bedtime. Consistent use is crucial for optimal results, even during symptom-free periods (as hypertension often presents asymptomatically). Common side effects include edema (ankle swelling), cephalalgia (headache), vertigo (dizziness), fatigue, and altered taste perception. Report any persistent, worsening, or bothersome side effects to your doctor. Maintain adequate hydration to minimize potential dehydration symptoms such as thirst, dry mouth, and muscle weakness. Prior to initiating treatment, inform your doctor of any pre-existing renal or hepatic impairment, pregnancy, or breastfeeding. Full disclosure of all current medications, particularly those for cardiovascular conditions, is essential. Regular monitoring of blood pressure, renal function, electrolyte balance, and glycemia is necessary to ensure therapeutic efficacy and safety.
Primary Ingredients of Telihep Trio 6.25 Tablet
No text was provided to rewrite.
Uses of Telihep Trio 6.25 Tablet
Elevated blood pressure
Major Benefits of Telihep Trio 6.25 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Telihep Trio 6.25 Tablet with food.
Common Side effects of Telihep Trio 6.25 Tablet:
- Ankle swelling
- Headache
- Dizziness
- Tiredness
- Palpitations
- Sleepiness
- Glucose intolerance
- Taste change
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Upset stomach
- Altered blood lipid level
How to use Telihep Trio 6.25 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Telihep Trio 6.25 Tablet whole; do not chew, crush, or divide it. Administer this medication with food.
How Telihep Trio 6.25 Tablet works:
Telihep Trio 6.25mg tablets contain telmisartan, cilnidipine, and chlorthalidone, working synergistically to manage hypertension. Telmisartan, an angiotensin II receptor antagonist, and cilnidipine, a dihydropyridine calcium channel blocker, both promote vasodilation, reducing blood pressure. Chlorthalidone, a thiazide diuretic, lowers blood pressure by increasing urinary excretion of sodium and water, contributing to overall vascular relaxation and improved circulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Telihep Trio 6.25 Tablet and alcohol is not advisable.
PregnancyCONSULT YOUR DOCTOR
Using Telihep Trio 6.25 Tablet during pregnancy poses a confirmed risk to the fetus. Its use should be avoided except in life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Always seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Telihep Trio 6.25 Tablet with breastfeeding is currently unavailable. Seek medical advice from your physician.
DrivingUNSAFE
Driving may be unsafe while taking Telihep Trio 6.25 Tablet due to potential side effects including drowsiness, blurred vision, and dizziness, which can impair alertness.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Telihep Trio 6.25 mg tablets, potentially requiring dosage modification under medical supervision. This medication is not advised for such individuals.
LiverCAUTION
Patients with liver impairment should use Telihep Trio 6.25 Tablet cautiously, potentially requiring dosage modification. A physician's consultation is advised. Telihep Trio 6.25 Tablet is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Telihep Trio 6.25 Tablet :
Should you forget a Telihep Trio 6.25 Tablet dose, administer it at your earliest convenience. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telihep Trio 6.25 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |




